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Abstract
Background: Lowering oxygen from atmospheric level (hyperoxia) to the physiological level (physioxia) of articular
cartilage promotes mesenchymal stem cell (MSC) chondrogenesis. However, the literature is equivocal regarding
the benefits of physioxic culture on preventing hypertrophy of MSC-derived chondrocytes. Articular cartilage
progenitors (ACPs) undergo chondrogenic differentiation with reduced hypertrophy marker expression in hyperoxia
but have not been studied in physioxia. This study sought to delineate the effects of physioxic culture on both cell
types undergoing chondrogenesis.
Methods: MSCs were isolated from human bone marrow aspirates and ACP clones were isolated from healthy
human cartilage. Cells were differentiated in pellet culture in physioxia (2 % oxygen) or hyperoxia (20 % oxygen)
over 14 days. Chondrogenesis was characterized by biochemical assays and gene and protein expression analysis.
Results: MSC preparations and ACP clones of high intrinsic chondrogenicity (termed high-GAG) produced abundant
matrix in hyperoxia and physioxia. Poorly chondrogenic cells (low-GAG) demonstrated a significant fold-change matrix
increase in physioxia. Both high-GAG and low-GAG groups of MSCs and ACPs significantly upregulated chondrogenic
genes; however, only high-GAG groups had a concomitant decrease in hypertrophy-related genes. High-GAG MSCs
upregulated many common hypoxia-responsive genes in physioxia while low-GAG cells downregulated most of these
genes. In physioxia, high-GAG MSCs and ACPs produced comparable type II collagen but less type I collagen than
those in hyperoxia. Type X collagen was detectable in some ACP pellets in hyperoxia but reduced or absent in
physioxia. In contrast, type X collagen was detectable in all MSC preparations in hyperoxia and physioxia.
Conclusions: MSC preparations and ACP clones had a wide range of chondrogenicity between donors. Physioxia
significantly enhanced the chondrogenic potential of both ACPs and MSCs compared with hyperoxia, but the
magnitude of response was inversely related to intrinsic chondrogenic potential. Discrepancies in the literature
regarding MSC hypertrophy in physioxia can be explained by the use of low numbers of preparations of variable
chondrogenicity. Physioxic differentiation of MSC preparations of high chondrogenicity significantly decreased
hypertrophy-related genes but still produced type X collagen protein. Highly chondrogenic ACP clones had
significantly lower hypertrophic gene levels, and there was little to no type X collagen protein in physioxia,
emphasizing the potential advantage of these cells.
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Background
Articular cartilage has limited potential to repair or
regenerate following acute injury and chronic
degeneration due to lack of a blood supply, low cell
density, and highly organized extracellular matrix. Tissue
engineering strategies to repair articular cartilage remain
limited by our inability to differentiate cells in vitro
toward the stable articular cartilage tissue phenotype,
which is characterized by high type II collagen and
aggrecan and low type I and type X collagen in the
extracellular matrix. Human bone marrow-derived
mesenchymal stem cells (MSCs) are an attractive candi-
date as an autologous cell source for tissue engineering
application because they are easily harvested through
bone marrow aspiration from adults; however, MSCs
invariably progress toward the hypertrophic phenotype
during in-vitro chondrogenesis [1, 2].
The physiologic oxygen tension (physioxia) within
tissues in the human body is well below the atmospheric
level (hyperoxia), with the highest level in the alveoli
(110 mmHg) and arterial blood (100 mmHg) [3].
Articular chondrocytes live in a physiologic environ-
ment of 1–5 % (8–40 mmHg) oxygen, and bone marrow
resides in approximately 7 % oxygen (50 mmHg) [3–5].
It is well known that oxygen deprivation in tissues stabi-
lizes expression of hypoxia-inducible factors (HIFs),
which directly modulate in-vitro chondrogenesis
through transactivation of regulatory transcription
factors, including sex determining region Y-box 9
(SOX9)—the master regulatory transcription factor for
chondrogenesis [6, 7]. Oxygen-mediated mechanisms
drive anabolism of the extracellular matrix molecules
toward the articular cartilage phenotype, but the role of
physioxia remains equivocal with regard to MSC
terminal differentiation toward the hypertrophic
phenotype.
We have found that genes of the hypertrophic pheno-
type, COL10A1 and MMP13, and of the fibrocartilaginous
phenotype, COL1A1, are significantly lower in both
healthy and osteoarthritic adult human chondrocytes dur-
ing redifferentiation in low-oxygen culture, which further
increases proteoglycan production and promotes expres-
sion of cartilage matrix genes, including COL2A1 and
ACAN [8]. The effect of lowered oxygen tension on
markers of hypertrophy during chondrogenic differenti-
ation of bone marrow-derived MSCs is less clear, with re-
sults ranging from downregulation [9–13] to no change
[14–16] to upregulation [17, 18] of COL10A1 and/or
MMP13. In our own previous work, we found that while
proteoglycan production and COL2A1 and ACAN expres-
sion are promoted in MSCs, COL10A1 expression is en-
hanced rather than suppressed in low-oxygen culture [17].
These studies, however, were conducted using MSCs that
had been expanded without FGF-2 supplementation,
which is known to improve subsequent chondrogenesis
[19–21], and the pellets exhibited poor chondrogenesis re-
gardless of oxygen tension. In our more recent studies,
using highly chondrogenic preparations, MSCs cultured at
low oxygen downregulated hypertrophic genes [12].
Articular cartilage progenitor (ACPs) cells are a cell
population that exists in the upper layer of mature ar-
ticular cartilage. They have generated significant interest
with regard to their role in tissue development [22–24],
in-situ response to injury [25–29], and tissue engineer-
ing [30–33]. Increasing evidence suggests that ACPs
generate stable articular chondrocytes of native tissue
through appositional growth of clonal populations [24].
In vitro, clonal ACPs undergo chondrogenic differenti-
ation with reduced potential for terminal differentiation
toward the hypertrophic phenotype, in contrast to MSCs
[31]. Further, chondrogenic potential is maintained with
extended population doublings and reduced telomere
shortening in subclonal populations [34]. Although
ACPs reside in a low-oxygen environment in vivo, where
oxygen tension likely influences both differentiation and
subsequent tissue homeostasis, the data concerning their
differentiation were all generated in a hyperoxic environ-
ment of 20 % oxygen in vitro.
While adult stem cells, including bone marrow-
derived MSCs and tissue-derived ACPs, are promising
cell candidates for autologous tissue regeneration,
there exists substantial heterogeneity across popula-
tions of cells from adult human donors [10, 35–38].
Generating clonal populations of MSCs is technically
very challenging. Among the few successful examples,
clonal MSC populations derived from individual
human donors demonstrate intraclonal heterogeneity
with respect to proliferative efficiency, differentiation
capacity, and phenotype [39, 40]. In contrast to
MSCs, ACPs are clonable, but intradonor variation
has only been defined at the level of colony-forming
efficiency [30], and intraclonal variation remains
undefined. Without standardized cell isolation and
differentiation protocols in articular cartilage tissue
engineering, generalized comparisons across and
within cell populations from adult human donors,
especially when pooled from multiple donors, may
hinder our ability to identify subsets of cells with
which to effectively generate autologous tissue applic-
able to adult patients.
The objective of the current study was to define the
influence of oxygen tension on chondrogenic differenti-
ation, specifically gene and protein expression, of adult
MSCs and ACPs. In particular, we focused on intradonor
variability of MSCs and both intradonor and intraclonal
variability of ACPs. We reasoned that not all adult hu-
man stem cells are equivalent, and there exists a range
of chondrogenic potential for cells derived from different
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biologic donors as well as for cells derived from clonal
populations from a single donor. This may have conse-
quences for understanding the response of stem cell
populations to biological stimuli; for example, the dis-
crepancies in reports on the effects of oxygen on MSC
hypertrophy. Thus, we investigated whether stem cell re-
sponses to changes in oxygen level during differentiation
depends on intrinsic chondrogenic capacity.
Methods
Cell harvest and isolation
Human MSCs were isolated from iliac crest bone mar-
row aspirates and expanded in monolayer culture as de-
scribed previously [1, 12]. Briefly, bone marrow aspirates
were obtained, with approval from the Institutional
Review Board at Oregon Health & Science University,
Portland, OR, USA (IRB00000605), from 14 consenting
donors (nine females, five males, age 46–74) and frac-
tionated on a Percoll density gradient. Cells were plated
at 160,000 cells/cm2 in low-glucose Dulbecco’s modified
Eagle medium (DMEM; Grand Island, NY, USA) with
10 % (v/v) fetal bovine serum (FBS) and 1 % (v/v) peni-
cillin–streptomycin (P/S). Adherent cells were cultured
at 37 °C, 5 % CO2 (atmospheric oxygen) with medium
changes every 3–4 days until confluent, at which point
expansion medium was supplemented with 10 ng/ml
basic fibroblast growth factor (FGF-2; PeproTech, Rocky
Hill, NJ, USA).
Normal articular cartilage from the femoral condyle of
four healthy human donors (all male, age 26–33) was
obtained with relevant ethical approval and informed
written consent from the NHS Blood and Tissue bank,
Liverpool, UK (NRES number: 09/WSE04/35). Chondro-
cytes from the full thickness tissue were isolated through
a sequential pronase (70 U/ml for 20 min at 37 °C) and
type I collagenase (300 IU/ml for 4 h at 37 °C) digestion.
Immediately following digestion, colony-forming cells
were isolated from the chondrocyte population through
differential adhesion to fibronectin [30]. A total of 18
clones from four biologic donors were evaluated. Cells
were expanded in DMEM/F12 (1:1) medium containing
1 mg/ml L-glucose, 10 mM HEPES, 10 % (v/v) FBS, 1 %
(v/v) P/S, 0.1 mM ascorbic acid 2-phosphate, 1 ng/ml
transforming growth factor β1 (TGFβ1; PeproTech), and
5 ng/ml FGF-2 (PeproTech).
Pellet culture
Chondrogenic differentiation was induced in serum-free
high-glucose DMEM containing 10 ng/ml TGF-β1
(PeproTech), 10–7 M dexamethasone (Sigma), 37.5 μg/ml
ascorbic acid 2-phosphate (Wako), 1 mM sodium pyru-
vate, 40 μg/ml L-proline, 1 % (v/v) ITS+ Universal Culture
Supplement Premix (BD Biosciences, San Jose, CA, USA),
and 1 % (v/v) P/S [1]. Pellet cultures were formed by
centrifuging 5 × 104 cells (MSCs) or 1 × 105 cells (ACPs) at
500 × g for 5 min in 240 μl of medium in Nunc polypro-
pylene V-bottom 96-well plates (Thermo Fisher Scientific,
Waltham, MA, USA). Cultures were maintained in a low-
oxygen incubator (Thermo) set at 2 % oxygen and 5 %
CO2 (physioxia), or in a standard tissue culture incubator
at 20 % oxygen and 5 % CO2 (hyperoxia). By convention,
we refer to the atmospheric, thus hyperoxic, condition as
20 % oxygen. Medium was changed every 2–3 days, with
that of the physioxic cultures being done at 2 % oxygen in
a low-oxygen chamber (BioSpherix, Lacona, NY, USA)
using medium pregassed to 2 % oxygen, ensuring cells
consistently saw that level of oxygen for the entire experi-
mental period.
Biochemical analysis
Triplicate pellets from each condition were rinsed
with phosphate-buffered saline (PBS) and digested
overnight at 60 °C in 4 U/ml papain (Sigma-Aldrich,
St Louis, MO, USA) in PBS containing 6 mM Na2-
ethylenediaminetetraacetic acid and 6 mM L-cysteine
(papain buffer, pH 6.0).
Total DNA and sulfated glycosaminoglycan (GAG)
content were quantified using Hoechst and 1,9-
dimethymethylene blue (DMMB) assays, respectively
[8]. The DNA content of pellet digests was quantified
using calf thymus DNA diluted in papain buffer as a
standard in serial dilution. Diluted samples, standards,
and blanks were added to Hoechst dye (2 μg/ml), and
fluorescence emission was measured with a multiwell
plate reader (excitation 355 nm, emission 455 nm).
Supernatant was collected at each medium change to
quantify the total amount of GAG produced and lost
into the medium. GAG content of pellet digests and
supernatant was quantified using shark chondroitin
sulfate (Sigma-Aldrich) diluted in either DMEM or
papain buffer as a standard in serial dilution. DMMB
dye (18 μg/ml in 0.5 % ethanol, 0.2 % formic acid,
30 mM sodium formate; pH 3.0) was added to samples,
standards, and blanks, and absorbance was measured
(575 nm).
Each cell type, MSCs and ACPs, was divided into two
groups based on GAG production in hyperoxia relative
to human chondrocytes cultured in standard chondro-
genic pellet culture conditions (n = 4 each of 5 × 104 and
1 × 105). Preparations or clones within two standard de-
viations of GAG production for the human chondrocytes
were considered high-GAG, and those below two stand-
ard deviations were considered low-GAG.
Gene expression analysis
RNA was isolated from six pellets of each replicate in
each condition. Briefly, pellets were pooled, snap frozen
directly in liquid nitrogen, crushed with a mini pestle,
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and lysed with Buffer RLT (QIAGEN, Germantown,
MD, USA) containing 40 mM dithiothreitol (DTT).
RNA isolation was performed with the RNeasy Mini
Kit (QIAGEN) according to the manufacturer’s in-
structions. Total RNA was quantified on a NanoDrop
Spectrophotometer (NanoDrop, Wilmington, DE, USA)
and 250–500 ng was reverse-transcribed using qScript
cDNA SuperMix (Quanta BioSciences, Gaithersburg, MD,
USA). Quantitative polymerase chain reaction (qPCR)
was performed with a 1:10 dilution of cDNA using a
StepOnePlus thermal cycler (Life Technologies, Grand
Island, NY, USA) with TaqMan Fast Advanced Master
Mix and the following TaqMan assay primers (Life
Technologies): COL2A1 (Hs00264051_m1), COL9A1
(Hs00932129_m1), COL11A2 (Hs00365416_m1), COL6A1
(Hs00242448_m1), COL1A1 (Hs00164004_m1), COL10A1
(Hs00166657_m1), SOX9 (Hs01001343_g1), L-SOX5
(Hs00374709_m1), SOX6 (Hs00264525_m1), ACAN
(Hs00153936_m1), PRG4 (Hs00195140_m1), LOX
(Hs00942480_m1), and MMP13 (Hs00233992_m1).
Cycling parameters were 50 °C for 2 min, 95 °C for
20 seconds, and then 95 °C for 1 second and 60 °C
for 20 seconds for a total of 40 cycles. Results were
analyzed using the 2–ΔCt method relative to 18S
(Hs99999907_m1) housekeeping gene—the most sta-
bly expressed of four evaluated housekeeping genes
across all experimental replicates and between groups.
Gene expression in physioxia was normalized to the
paired gene in hyperoxia to calculate the relative fold-
change expression.
To evaluate a panel of oxygen tension-mediated genes,
RNA was pooled at equal quantities from each group,
and 5 ng of cDNA was loaded into each well of a human
TaqMan gene array (catalog number #4414090; Life
Technologies). Results were analyzed using the 2–ΔCt
method relative to 18S housekeeping gene, consistent
with single gene analysis. A cycle threshold of 36 was de-
fined for minimum expression levels across the panel,
and undetectable genes above the threshold were not
evaluated. Gene expression in physioxia was normalized
to the paired gene in hyperoxia to calculate the relative
fold-change expression. Heatmaps were generated in
RStudio (Boston, MA, USA): one without scaling to re-
flect the fold-change expression; and one with a z-score
cluster analysis. Gene relationships were defined using
the STRING (Search Tool for the Retrieval of Interacting
Genes/Proteins) database v10, and genes were grouped
according to common biological processes of gene
ontology.
Histology and immunohistochemistry
Pellets were fixed in 10 % neutral buffered formalin, em-
bedded in paraffin, and sectioned onto slides. Proteogly-
can content was visualized by histochemical staining
with toluidine blue (0.04 % toluidine blue, 0.2 M acet-
ate buffer, pH 4.00) after deparaffinization. Pellet size
was determined by measuring the widest diameter
with digital analysis of toluidine blue-stained sections
taken from the middle of the pellet (ZEN blue; Ziess,
Oberkochen, Germany).
For immunohistochemistry, sections were deparaffi-
nized and pretreated for antigen retrieval. For type X
collagen, sections were treated with 1 mg/ml protease
(Roche) in PBS for 30 min at room temperature. For
type I and type II collagen, protease treatment was
followed by 1 mg/ml hyaluronidase in PBS for 30 min at
37 °C. Sections were blocked with a blocking buffer
composed of 4 % normal goat serum (NGS), 1 % bovine
serum albumin (BSA), and 0.3 % Triton X-100 in 1×
PBS, and were subsequently probed with primary anti-
bodies to type X collagen (mouse polyclonal antibody,
1:300; kind gift from GJ Gibson, Henry Ford Hospital,
Detroit, MI, USA), type I collagen (rabbit polyclonal
antibody, 1:200; kind gift from A Hollander, University
of Bristol, Bristol, UK), and type II collagen (II-II6B3
mouse monoclonal antibody, 1:200; Developmental
Studies Hybridoma Bank, University of Iowa, Iowa City,
IA, USA) overnight at 4 °C. Secondary antibodies, in-
cluding Oregon Green-conjugated anti-rabbit (1:250)
and Alexa Fluor 596-conjugated anti-mouse (1:250) (Life
Technologies) in blocking buffer, were incubated on the
slides for 45 min at room temperature. Slides were
mounted with ProLong Gold antifade reagent containing
4′,6-diamidino-2-phenylindole (DAPI; Life Technologies)
and imaged at 20× using a Leica DM4000b upright fluor-
escent microscope (Leica Microsystems, Buffalo Grove,
IL, USA).
Western blotting
To confirm the presence of protein visualized in immu-
nohistochemistry, 10 pellets from ACP clones were
digested in 8 M urea under reducing conditions. Total
protein concentration was quantified through a BCA
Assay (Thermo), and equal quantities were loaded onto
an 8 % polyacrylamide gel. Gels were transferred to poly-
vinylidene difluoride (PVDF) membrane, blocked with
2 % nonfat milk, and probed for type X collagen for 1 h
at room temperature with a primary antibody to the hel-
ical domain (X53, HRP-conjugated mouse monoclonal
antibody, 1:5000). The X53 antibody was characterized
as described by Girkontaite et al. [41], and full-length
collagen type X stably expressed in HEK293 cells was
affinity purified as outlined in Wagner et al. [42].
Both reagents were kindly provided by Greg Lunstrum
of the Shriners Hospital for Children, Portland, OR, USA.
As a loading control, the membrane was probed with a
primary antibody to GAPDH (MAB374 mouse monoclo-
nal antibody, 1:300; EMD Millipore, Darmstadt, Germany)
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for 1 h at room temperature and subsequently probed
with HRP-conjugated goat anti-mouse (sc2005, 1:5000;
Santa Cruz Biotechnology, Dallas, TX, USA) for 45 min at
room temperature. HRP-conjugated antibodies were
reacted with Western Lighting Plus ECL (Perkin Elmer,
Waltham, MA, USA) chemiluminescence HRP substrate
and visualized with a c-Digit blot scanner (LI-COR,
Lincoln, NE, USA).
Statistical analysis
All statistical analyses were performed using GraphPad
Prism v6.0 (GraphPad, La Jolla, CA, USA). Normality for
each condition within a single cell type was assessed using
a D’Agostino–Pearson omnibus K2 test, with normally dis-
tributed groups not meeting significance of p < 0.05 for
distribution other than Gaussian. Comparison of GAG
content and gene expression between physioxia and hyper-
oxia within a given group was assessed using a paired t test
for normal data and a Wilcoxon matched-pairs signed rank
test for nonnormal data, with significance set at p < 0.05.
Comparison of GAG content between normally distributed
groups was performed with an unpaired t test, with signifi-
cance set at p < 0.05. Mean and standard deviation for
fold-change gene expression was calculated as physioxia
relative to hyperoxia for each group.
Results
Stem cell populations vary in their response to physioxia
during chondrogenic differentiation
Quantification of total GAG per pellet as a readout for
overall chondrogenic differentiation revealed that culture
in physioxia significantly favored chondrogenic extracel-
lular matrix anabolism when compared with culture in
hyperoxia (p = 0.0002 for MSCs, p = 0.0124 for ACPs).
There existed a wide range of both baseline GAG con-
tent in hyperoxia and fold-change GAG content from
hyperoxia to physioxia across individual populations of
cells (Fig. 1a). Each biologic replicate of MSCs and ACPs
was categorized as high-GAG or low-GAG based on a
threshold defined by their total GAG production in
hyperoxia relative to that of pellet cultures of healthy
human articular chondrocytes in the same conditions
(Additional file 1: Figure S1). Specifically, cell popula-
tions that produced GAGs within two standard devia-
tions of human chondrocyte pellets were considered
high-GAG cells, and those below the two standard devi-
ation threshold were considered low-GAG cells. While
Fig. 1 a Total glycosaminoglycan (GAG) production per pellet for each MSC preparation and ACP clone indicated variation among human
donors. A threshold (dashed line) defined as two standard deviations from the total GAG production during pellet chondrogenesis for healthy
human chondrocytes was set for each cell type, and low-GAG and high-GAG groups were categorized. b Mean (± SD) fold-change GAG production in
physioxia relative to hyperoxia was significant for all groups other than high-GAG ACPs, and a significant difference existed between the fold-change
for low-GAG and high-GAG groups of each cell type. c Mean (± SD) fold-change DNA content in physioxia relative to hyperoxia was no different
between oxygen level, GAG level, nor cell type. Statistical significance defined as *p < 0.05, ***p < 0.001. ACP articular cartilage progenitor,
MSC mesenchymal stem cell
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physioxic culture increased GAG production across all
MSC preps and the majority of ACP clones, physioxia
was of greater benefit to biologic replicates that exhib-
ited very low GAG production at baseline in hyperoxia,
driving a greater fold-change than for clones that started
with high GAG production and chondrogenic capacity
in hyperoxia (Fig. 1b). There were no statistically significant
differences in pellet DNA content between oxygen levels,
GAG levels, or cell types, indicating that differences in
GAG content were not due to cell proliferation or death
(Fig. 1c). Even with a significantly higher fold-induction, the
pellets of low-GAG cell preparations of both cell types were
still poorly chondrogenic in comparison with matched
high-GAG pellets. This can also be discerned easily in the
qualitative analysis of proteoglycan and glycosaminoglycan
production through toluidine blue staining and quantitative
analysis of pellet size; low-GAG pellets of each cell type
were significantly smaller in pellet diameter with much
less metachromasia than high-GAG pellets of the same
cell type (Fig. 2).
Effect of physioxia on gene expression corresponds with
intrinsic chondrogenic capacity
All cell preparations and clones were evaluated for chon-
drogenic markers, including those of the articular chondro-
cyte (COL2A1, ACAN), the fibrochondrocyte (COL1A1),
and the hypertrophic chondrocyte (COL10A1, MMP13)
phenotypes. Physioxic culture significantly upregulated
COL2A1 and ACAN in low-GAG preparations from
both cell types (Fig. 3). However, among low-GAG
cells, only ACPs demonstrated significant downregula-
tion of COL10A1 while MSCs did not downregulate
either marker of the hypertrophic phenotype, COL10A1
or MMP13. Physioxic culture of the high-GAG cells
demonstrated significant upregulation of COL2A1 and
ACAN for both ACPs and MSCs, with a corresponding
significant downregulation of COL10A1 and MMP13
relative to culture in hyperoxia. Only high-GAG MSCs
demonstrated a significant downregulation of COL1A1
gene expression.
Oxygen-dependent genes are differentially expressed
between groups of low and high chondrogenicity
When evaluated for a panel of oxygen-responsive genes,
high-GAG MSCs and ACPs displayed a different expres-
sion pattern to the matched low-GAG group for each
cell type. Based on cluster analysis, cell groups were
more closely related based on GAG production and
intrinsic chondrogenicity than on cell type; low-GAG
MSCs and ACPs clustered together, which then clus-
tered with high-GAG ACPs, and finally with high-GAG
MSCs (Fig. 4). When evaluated as the relative fold-
change from hyperoxia to physioxia (Additional file 2:
Figure S2), high-GAG MSCs upregulated a majority
(80 %) of oxygen-responsive genes, including those of
the HIF regulatory and TGF-β signaling pathways, both
of which modulate chondrogenic differentiation. These
cells also either upregulated or did not change oxygen-
responsive genes that regulate other biological processes,
grouped by gene ontology, including cell cycle control,
metabolism, and angiogenesis; many genes were involved
in two or more processes. In contrast, low-GAG MSCs
downregulated 74 % of these same genes across all
groupings. Both high-GAG and low-GAG ACPs down-
regulated a majority of these oxygen-dependent genes,
and the response between groups was similar in magni-
tude as well as direction for most genes.
Physioxia promotes the articular chondrocyte phenotype
in highly chondrogenic cells
High-GAG cells of both MSCs and ACPs demonstrated
significant upregulation of COL2A1, COL11A2, COL6A1,
Fig. 2 a Representative toluidine blue stain for total proteoglycans demonstrates smaller pellets with less metachromasia for low-GAG MSC
preparations and ACP clones in both hyperoxia and physioxia relative to paired high-GAG MSC preparations and ACP clones at the respective oxygen
levels. Images were acquired with bright-field microscopy, scale bars= 100 μm. b Measurement of pellet diameter revealed a statistically significant
difference in pellet size between both MSCs and ACPs of high or low chondrogenicity and between high-GAG MSCs at physioxia or
hyperoxia. Statistical significance defined as *p < 0.05, **p < 0.01, ****p < 0.0001. ACP articular cartilage progenitor, GAG glycosaminoglycan,
MSC mesenchymal stem cell
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ACAN, PRG4, and SOX9 and downregulation of
COL10A1 and MMP13 in physioxia relative to hyperoxia
(Fig. 5, Additional file 3: Table S1). High-GAG MSC
preparations also demonstrated significant upregulation
of COL9A1 and L-SOX5 and downregulation of COL1A1
in physioxia. High-GAG ACP clones further demon-
strated significant upregulation of SOX6 and LOX.
COL9A1 was undetectable in five of eight high-GAG
ACP clones cultured in hyperoxia but present at detect-
able levels in all clones cultured in physioxia.
Physioxia promotes collagen protein expression
representative of articular cartilage
Culture of high-GAG MSCs and ACPs in both physioxic
and hyperoxic environments generated cartilage pellets
with robust type II collagen expression throughout
Fig. 3 Gene expression analysis for fold-change of chondrogenic markers of the articular cartilage phenotype (COL2A1, ACAN), the fibrocartilaginous
phenotype (COL1A1), and the hypertrophic phenotype (COL10A1, MMP13) demonstrates varied chondrogenic responses by high-GAG and low-GAG
groups of each cell type, MSCs and ACPs, during pellet culture in physioxic relative to hyperoxic conditions. Data are mean ± standard deviation of
fold-change for each group (n = 6–10). Statistical significance defined as *p < 0.05 by a paired or unpaired t test where appropriate. # p < 0.05 between
low and high GAG pellets. ACP articular cartilage progenitor, GAG glycosaminoglycan, MSC mesenchymal stem cell
Fig. 4 Clustering of oxygen-dependent gene expression based on z-score demonstrates that groups of MSCs and ACPs are more similar between
GAG level than within cell type in response to culture in physioxia relative to culture in hyperoxia. ACP articular cartilage progenitor, GAG
glycosaminoglycan, MSC mesenchymal stem cell
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(Fig. 6). MSCs cultured in hyperoxia exhibited highest
type I collagen expression in the outer region of the pel-
let, whereas MSCs cultured in physioxia demonstrated
less staining of extracellular type I collagen, consistent
with significant downregulation of COL1A1. Similarly,
high-GAG ACPs demonstrated a reduction in extracellular
type I collagen in physioxia compared with hyperoxia. Type
X collagen remained consistently high in all high-GAG
MSC preparations evaluated, regardless of oxygen tension.
Conversely, high-GAG ACPs cultured in hyperoxia demon-
strated variable type X collagen protein between clones,
ranging from abundant to absent. Significantly, type X
Fig. 5 Gene expression analysis for fold-change of chondrogenic markers in physioxia relative to hyperoxia demonstrates that high-GAG groups
of both MSCs and ACPs are highly responsive to oxygen level and upregulate a majority of genes representative of the articular cartilage
phenotype in low-oxygen environments. Data are mean ± standard deviation of fold-change in gene expression for each group (n = 8).
Statistical significance defined as *p < 0.05 by a paired t test for normal data and a Wilcoxon matched-pairs signed rank test for nonnormal data. ACP
articular cartilage progenitor, MSC mesenchymal stem cell
Fig. 6 Representative immunohistochemistry demonstrates that cartilage pellets cultured in hyperoxia (20 % oxygen) and physioxia (2 % oxygen)
exhibit oxygen-dependent expression of extracellular collagen protein, including type II collagen (a–d) of the articular cartilage phenotype, type I
collagen (e–h) of the fibrocartilaginous phenotype, and type X collagen (i–n) of the hypertrophic phenotype. Type X collagen expression was
variable among ACP clones differentiated in hyperoxia (k, m). Nuclei were counterstained with DAPI, and composite images of collagen staining
and nuclei were digitally merged using ImageJ software (National Institutes of Health, Bethesda, MD, USA). Negative controls with isotype-matched
antibodies were used for background correction (images not shown). Scale bars= 100 μm. ACP articular cartilage progenitor, MSC mesenchymal
stem cell
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collagen protein expression was undetectable in the extra-
cellular matrix of all clones cultured in physioxia. Western
blots of pellet extracts with antibodies to type X collagen
generated consistent results with little to no detect-
able protein in ACP clones at physioxia (Additional
file 4: Figure S3).
Discussion
From our results, we can state that physioxia promotes
the stable articular cartilage phenotype at both the gene
and protein levels during chondrogenic differentiation of
ACPs in three-dimensional culture. MSCs demonstrated
a similar response with respect to gene expression; how-
ever, type X collagen expression persisted in the phy-
sioxic environment. The magnitude of anabolic response
to culture in physioxia was inversely related to the in-
trinsic chondrogenic potential in hyperoxia for both cell
types. To account for differences in the chondrogenic
capacity of stem cells at baseline, we divided the cell
populations based on total GAG production. Those that
produced low quantities of GAGs in a hyperoxic envir-
onment gained significant benefit from culture in phy-
sioxia but not enough to elaborate the matrix to the
levels produced by cells with high intrinsic chondrogenic
capacity. In contrast, cells that produced high quantities
of GAGs in hyperoxia did not respond as robustly to
lowered oxygen; these cells may be closer to reaching
their maximum rate of proteoglycan synthesis that
oxygen-related mechanisms are unable to further in-
crease. The differences in GAG production between rep-
licates and clones was due to enhanced anabolism and
not cell proliferation or death, as the DNA content was
not different between these groups. While we did not
directly measure the influence of donor age or gender
on variation in chondrogenic capacity, the wide range
across ACP clones and replicates, which were all derived
from young males, demonstrates the extent of variation
in human cells; these cells showed as wide a range in
chondrogenicity as MSCs, which were derived from
older male and female donors.
For low-GAG MSCs and ACPs, a significant increase
in markers of the articular cartilage tissue phenotype, in-
cluding GAG content and COL2A1 and ACAN gene
expression, was not complemented by significantly
decreased expression of both hypertrophic genes,
COL10A1 and MMP13. Despite a substantial fold-
change in chondrogenic markers from hyperoxia to phy-
sioxia, these cells produced consistently smaller and
more fibrous pellets in comparison with the high-GAG
producers of the same cell type. In contrast, high-GAG
MSC preparations and ACP clones significantly down-
regulated hypertrophic markers with culture in physioxia,
demonstrating a distinct phenotypic difference between
groups of cells of varied chondrogenic differentiation
potential at baseline. Differences in gene expression be-
tween high-GAG and low-GAG preparations were not
limited to genes of chondrogenic differentiation; at low
oxygen tension, high-GAG MSCs upregulated canonical
hypoxia-responsive genes—including those of HIF regula-
tion, constituents of TGF-β and IGF signaling, and cell
cycle regulators—relative to hyperoxic culture. In contrast,
low-GAG MSCs were most similar to ACPs of low chon-
drogenicity, because both downregulated or did not
change a majority of these oxygen-responsive genes in
response to culture in physioxia. Expression of oxygen-re-
sponsive genes for high-GAG ACPs clustered with
high-GAG MSCs and the grouping of low-GAG cell pop-
ulations, indicating a mid-range response to physioxia in
comparison with high-GAG MSCs, which were most
responsive to physioxia. The differences between MSCs of
high and low chondrogenicity in both direction and mag-
nitude may be due to the cellular heterogeneity within a
given preparation, which represents the total population
of plastic adherent mononuclear cells from a bone mar-
row aspirate. Poorly chondrogenic cells expanded from
this material may originate from a different population of
cells than highly chondrogenic cells, and their dramatically
different response across oxygen-dependent genes indi-
cates they are indeed very different cells, not simply differ-
ent in their ability to express cartilage genes and elaborate
matrix. ACPs, on the contrary, are selected based on
expression of specific integrins from a comparatively
homogeneous initial pool of cells. These cells correspon-
dingly are overall much more similar in their response to
changes in oxygen, regardless of their ability to produce
matrix-rich tissue. Taken together, our findings regarding
both chondrogenic and oxygen-dependent gene expres-
sion indicate that low-GAG MSCs may be intrinsically
limited in their overall response to altered oxygen levels.
Discrepancies in the literature regarding MSC hyper-
trophy during chondrogenic differentiation in lower oxy-
gen may be due to inclusion of preparations of low
chondrogenic capacity, and the present results demon-
strate wide variation not previously taken into consider-
ation for either cell type when examining their responses
to alterations in oxygen level. An earlier study of MSC
chondrogenesis in lowered oxygen tension reported a
significant upregulation of COL10A1 for cells expanded
without FGF-2 [17], which is known to aid retention of
chondrogenic capacity in these cells [19–21]. Our later
studies demonstrated a significant downregulation of
hypertrophic genes when differentiating MSCs of previ-
ously defined high chondrogenic capacity in lowered
oxygen [12]. Other recent studies have also reported
downregulation of hypertrophic genes during MSC
differentiation in lowered oxygen tension [9–11, 13].
Adesida et al. [9] reported that MSCs expanded and
differentiated in pellet culture at low oxygen tension
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significantly downregulate COL10A1 in comparison with
hyperoxic cultured MSCs; however, Bornes et al. [16]
from the same laboratory found no change in COL10A1
expression for ovine MSCs cultured at low and high
oxygen in a scaffold-based culture system. Studies of a
larger set of human MSC preparations found no change
in COL10A1 expression with culture in physioxia when
compared with hyperoxia, but these studies did not
characterize individual preparations for baseline chon-
drogenicity [14, 15]. Finally, Duval et al. [11] showed
that COL10A1 expression is downregulated in the pres-
ence of HIF-1α and upregulated with blockade of this
protein; however, mechanisms underlying HIF activity
and COL10A1 expression remain unclear [12, 43–45].
Based on our investigation, we suggest that the variation
in the reported results for the hypertrophic response of
MSCs in lowered oxygen tension may be due to the
disparity of the intrinsic chondrogenic capacity of these
cells at baseline: highly chondrogenic cells significantly
downregulate genes of hypertrophy, and cells of lower
chondrogenic potential are much less responsive.
We reasoned that that cells of low chondrogenic cap-
acity, such as the low-GAG MSC preparations and ACP
clones, are unsuitable candidates for articular cartilage
tissue engineering application and focused on the re-
sponses of high-GAG cells to culture in physioxia to fur-
ther characterize the effects of oxygen on the articular
chondrocyte phenotype. In low-oxygen conditions, HIF-
1α and HIF-2α are considered prochondrogenic through
induction of SOX9, the gene coding for the master tran-
scriptional regulator of chondrogenesis, SOX9, that in
turn promotes COL2A1 and ACAN gene expression to
drive extracellular matrix anabolism of type II collagen
and aggrecan, respectively [46, 47]. As expected, both
MSCs and ACPs significantly upregulated SOX9 in re-
sponse to lowered oxygen, and MSCs significantly up-
regulated L-SOX5, the gene for a complementary
chondrogenic transcription factor, while ACPs signifi-
cantly upregulated SOX6. HIF-1α has also been reported
to activate transcription of LOX—the gene coding for
lysyl oxidase, which is an enzyme that catalyzes collagen
crosslinking in articular cartilage through a hypoxia-
responsive element (HRE) [48], but only ACPs demon-
strated a significant upregulation of LOX. Conclusions
regarding the regulation of PRG4, the gene for lubricin,
in response to alterations in oxygen vary in the litera-
ture, even though PRG4 also contains an HRE in the
promoter region [45, 49, 50]. We have shown here that
highly chondrogenic cells upregulated PRG4 gene ex-
pression in physioxia. COL9A1, COL11A1, and COL6A1,
the genes for type IX, type XI, and type VI collagen re-
spectively, were upregulated in both cell types, indicating
that the collagen network is extensively influenced by
lowered oxygen tension toward the articular phenotype.
Only MSCs demonstrated a significant downregulation
of COL1A1; however, both MSCs and ACPs demon-
strated a reduction of extracellular type I collagen pro-
tein with culture in physioxia, indicating the influence of
oxygen on posttranslational modifications of the colla-
gen network formed by these cells. Specifically, proline
hydroxylation is a necessary step for successful collagen
secretion, and this oxygen-dependent enzymatic reaction
may be attenuated in low-oxygen environments [51].
When oxygen is limited, chondrogenic cells may prefer-
entially secrete type II over type I collagen, as COL2A1
is upregulated in an oxygen-dependent manner through
HIF regulation [47]. Consistent with this hypothesis,
our group has shown that articular chondrocytes also
downregulate type I collagen at both the gene and
protein levels in response to lowered oxygen tension
[8]. These findings indicate that culture in low oxygen
favors the articular chondrocyte phenotype over the
fibrocartilage phenotype for multiple cell types.
The findings in this study are in agreement with recent
reports on the beneficial effect of low oxygen in redu-
cing markers of hypertrophy at the gene level in MSCs
[9, 12, 13], at least for our preparations of high chondro-
genic capacity. Although highly chondrogenic MSC
preparations significantly downregulated hypertrophic
genes in physioxia, these cells still produced a matrix
rich in type X collagen protein. Prior studies that re-
ported a decrease in COL10A1 for MSCs differentiated
in low oxygen did not evaluate type X collagen protein
expression [9, 12, 13]. Leijten et al. [13] reported recently
that low-oxygen culture of MSCs abrogated expression of
typical hypertrophic markers at the mRNA level and di-
minished subsequent vascular invasion and ossification of
implanted constructs. While this may indeed be a benefit
of low-oxygen culture, we show that such preconditioning
still likely results in tissue rich in type X collagen protein
and this may have consequences unrelated to endochon-
dral ossification. Ultimately, type X collagen establishes a
tissue phenotype with increased stiffness that is not suited
for articular cartilage repair [52]. Culture of MSC-derived
cartilage at physioxia does not overcome the long-noted
challenge of controlling MSC differentiation to avoid
creating the hypertrophic phenotype.
In the initial characterization of chondrogenic differ-
entiation of ACPs in hyperoxia, Williams et al. [30] did
not find clones that produced detectable type X collagen
at the protein level. In contrast, we found that some
ACP clones produced abundant type X collagen in the
hyperoxic environment. This notwithstanding, none of
the clones produced detectable type X collagen in the
physioxic environment. While both MSCs and ACPs of
high chondrogenicity express COL10A1, differences in
protein expression between physioxia and hyperoxia
indicate that these two stem cell populations may have
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different translational control over this gene. The differ-
ence in translational control will be the subject of future
studies. Regardless of the mechanism, ACP culture in
physioxia consistently promotes a favorable tissue pheno-
type when compared with MSC-derived tissue.
Conclusions
The variation in chondrogenic capacity among stem/
progenitor cell populations from adult human tissues is
an important consideration in tissue engineering. Our
work suggests that laboratories ought to perform initial
assays to characterize individual populations of human-
derived stem cells, because variation in intrinsic chon-
drogenicity will influence experimental results, especially
for studies with a small sample size. Although the im-
pact of intrinsic chondrogenicity was not evaluated in
vivo, we further reason that individual stem cell popula-
tions intended for allogeneic or autologous tissue repair
should be characterized in vitro to identify highly chon-
drogenic cells prior to application in tissue-engineered
therapies. We have shown that the chondrogenic cap-
acity of stem cells influences the cell’s response to cul-
ture in a physiologic low-oxygen environment: in
physioxia, both MSCs and ACPs of high chondrogenicity
demonstrate upregulation of the articular chondrocyte
phenotype and downregulation of the hypertrophic
phenotype. Only ACPs, however, demonstrate a consistent
attenuation of type X collagen in the physioxic environ-
ment, and these cells may overcome historical challenges
of MSC hypertrophy in tissue engineering applications.
Additional files
Additional file 1: Figure S1 showing total glycosaminoglycan (GAG)
production per pellet for healthy human chondrocytes cultured at
densities of 100,000 or 50,000 cells per pellet over 14 days of chondrogenic
differentiation. Two standard deviations below the mean of each group
(dotted line) was used to define the threshold for grouping MSC and ACP
preparations based on proteoglycan production for the matched cell
density. (TIFF 491 kb)
Additional file 2: Figure S2 showing fold-change gene expression from
hyperoxia to physioxia across an array of oxygen-dependent genes, and
demonstrates differential expression patterns between high-GAG and
low-GAG groups of each cell type, MSCs and ACPs. Genes labeled in
green were upregulated in physioxia relative to hyperoxia, and genes
labeled in red were downregulated in physioxia relative to hyperoxia.
Genes were categorized according to associations of gene ontology for
biologic processes based on associations and clusters in the STRING
database. (TIF 8318 kb)
Additional file 3: Table S1 presenting gene expression. (PDF 72 kb)
Additional file 4: Figure S3 showing western blots to detect type X
collagen in total protein lysates from ACP pellets cultured for 14 days,
and demonstrates that ACPs either lack type X collagen expression in all
conditions or reduce expression with culture in physioxia relative to
culture in hyperoxia. (TIF 4269 kb)
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